Menu Search
Equities

Shandong Weigao Group Medical Polymer Co Ltd

UK2:STU

Shandong Weigao Group Medical Polymer Co Ltd

Actions
  • Price (EUR)0.61
  • Today's Change0.015 / 2.52%
  • Shares traded0.00
  • 1 Year change-59.60%
  • Beta--
Data delayed at least 15 minutes, as of Apr 30 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Shandong Weigao Group Medical Polymer Co., Ltd. is principally engaged in the research and development, production and sale of single-use medical devices. The Company sells products under brand names of Jierui and Wego Ortho. The Company operates through three business segments. The Single Use Medical Device Products segment is engaged in the production and sale of single-use consumables, such as infusion sets, syringes, blood transfusion sets and blood bags. The Orthopaedic Products segment is engaged in the production and sale of orthopaedic products. The Blood Purification Products segment is engaged in the production and sale of blood purification products and related medical equipment. The Company is also engaged in the manufacture of industrial automatic equipment and parts, as well as the provision of logistics and storage services through its subsidiaries.

  • Revenue in HKD (TTM)14.31bn
  • Net income in HKD2.17bn
  • Incorporated2000
  • Employees12.52k
  • Location
    Shandong Weigao Group Medical Polymer Co LtdNo.18 Xingshan RoadTorch Hi-Tech Industry Development ZoneWEIHAI 264210ChinaCHN
  • Phone+86 6 315621999
  • Fax+86 6 315621999
  • Websitehttps://www.weigaoholding.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.